Study on the Use of Inhaled NO (iNO)

CompletedOBSERVATIONAL
Enrollment

239

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

October 31, 2015

Conditions
Pulmonary Hypertension
Interventions
DRUG

Inhaled Nitric Oxide with monitoring by EZ-KINOX device

Trial Locations (14)

1200

Cliniques Universitaires ST Luc, Brussels

21079

Hôpital du Bocage Central, Dijon

31076

Clinique Pasteur, Toulouse

33604

Hôpital Haut-Lévèque, Bordeaux

34295

CHU Montpellier - Hôpital Arnaud de Villeneuve, Montpellier

Hôpital Arnaud de Villeneuve, Montpellier

44093

CHU de Nantes - Hôpital Laennec, Nantes

Hôpital Hôtel Dieu, Nantes

51092

American Memorial Hospital, Reims

75012

Hôpital Trousseau, Paris

75015

Hôpital Necker-Enfants Malades, Paris

75651

Hôpital Pitié-Salpêtrière, Paris

75743

Hôpital Necker-Enfants Malades, Paris

Unknown

CHU Sart TILMAN, Liège

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Euraxi Pharma

INDUSTRY

lead

Air Liquide Santé International

INDUSTRY

NCT02821156 - Study on the Use of Inhaled NO (iNO) | Biotech Hunter | Biotech Hunter